Klotho converts canonical FGF receptor into a specific receptor for FGF23
Top Cited Papers
Open Access
- 29 October 2006
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 444 (7120) , 770-774
Abstract
The klotho gene was first identified as a mutation in a mouse strain that exhibits a syndrome resembling human ageing, and overexpression of klotho extends the lifespan of mice. A possible mechanism of action for the Klotho protein has now been found: it converts FGFR1(IIIc), a receptor for various fibroblast growth factors acting at a local level, into a specific receptor for FGF23, a bone-derived hormone that regulates kidney function. FGF23 is a unique member of the fibroblast growth factor (FGF) family because it acts as a hormone that derives from bone and regulates kidney functions, whereas most other family members are thought to regulate various cell functions at a local level1,2,3,4,5. The renotropic activity of circulating FGF23 indicates the possible presence of an FGF23-specific receptor in the kidney6. Here we show that a previously undescribed receptor conversion by Klotho, a senescence-related molecule7, generates the FGF23 receptor. Using a renal homogenate, we found that Klotho binds to FGF23. Forced expression of Klotho enabled the high-affinity binding of FGF23 to the cell surface and restored the ability of a renal cell line to respond to FGF23 treatment. Moreover, FGF23 incompetence was induced by injecting wild-type mice with an anti-Klotho monoclonal antibody. Thus, Klotho is essential for endogenous FGF23 function. Because Klotho alone seemed to be incapable of intracellular signalling, we searched for other components of the FGF23 receptor and found FGFR1(IIIc), which was directly converted by Klotho into the FGF23 receptor. Thus, the concerted action of Klotho and FGFR1(IIIc) reconstitutes the FGF23 receptor. These findings provide insights into the diversity and specificity of interactions between FGF and FGF receptors.Keywords
This publication has 31 references indexed in Scilit:
- Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlothoJournal of Clinical Investigation, 2005
- FGF-21 as a novel metabolic regulatorJournal of Clinical Investigation, 2005
- Evolution of the Fgf and Fgfr gene familiesTrends in Genetics, 2004
- Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient miceMatrix Biology, 2004
- Secreted Klotho protein in sera and CSF: implication for post‐translational cleavage in release of Klotho protein from cell membraneFEBS Letters, 2004
- FGF-23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate HomeostasisJournal of Bone and Mineral Research, 2004
- Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteersKidney International, 2003
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- Fibroblast Growth Factor (FGF)-23 Inhibits Renal Phosphate Reabsorption by Activation of the Mitogen-activated Protein Kinase PathwayJournal of Biological Chemistry, 2002
- Molecular cloning and expression analyses of mouse βklotho, which encodes a novel Klotho family proteinMechanisms of Development, 2000